TGFB1 and cancer: Moreover, evidence suggests that CAFs contribute to therapy resistance through different mechanisms, such as via cell–matrix and cell–cell interactions that control cell survival and through paracrine signaling to cancer cells upon the secretion of pro-survival factors and a variety of modulatory molecules like TGF-β [54].